Cargando…

Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer’s disease

Detalles Bibliográficos
Autores principales: Coughlin, David G., Goodwill, Vanessa S., Standke, Heidi G., Kim, Yongya, Coley, Nicolas, Pizzo, Donald P., Galasko, Douglas, Kraus, Allison, Hiniker, Annie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467964/
https://www.ncbi.nlm.nih.gov/pubmed/35980456
http://dx.doi.org/10.1007/s00401-022-02480-x
_version_ 1784788308450082816
author Coughlin, David G.
Goodwill, Vanessa S.
Standke, Heidi G.
Kim, Yongya
Coley, Nicolas
Pizzo, Donald P.
Galasko, Douglas
Kraus, Allison
Hiniker, Annie
author_facet Coughlin, David G.
Goodwill, Vanessa S.
Standke, Heidi G.
Kim, Yongya
Coley, Nicolas
Pizzo, Donald P.
Galasko, Douglas
Kraus, Allison
Hiniker, Annie
author_sort Coughlin, David G.
collection PubMed
description
format Online
Article
Text
id pubmed-9467964
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-94679642022-09-14 Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer’s disease Coughlin, David G. Goodwill, Vanessa S. Standke, Heidi G. Kim, Yongya Coley, Nicolas Pizzo, Donald P. Galasko, Douglas Kraus, Allison Hiniker, Annie Acta Neuropathol Correspondence Springer Berlin Heidelberg 2022-08-18 2022 /pmc/articles/PMC9467964/ /pubmed/35980456 http://dx.doi.org/10.1007/s00401-022-02480-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Coughlin, David G.
Goodwill, Vanessa S.
Standke, Heidi G.
Kim, Yongya
Coley, Nicolas
Pizzo, Donald P.
Galasko, Douglas
Kraus, Allison
Hiniker, Annie
Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer’s disease
title Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer’s disease
title_full Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer’s disease
title_fullStr Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer’s disease
title_full_unstemmed Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer’s disease
title_short Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer’s disease
title_sort selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in alzheimer’s disease
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467964/
https://www.ncbi.nlm.nih.gov/pubmed/35980456
http://dx.doi.org/10.1007/s00401-022-02480-x
work_keys_str_mv AT coughlindavidg selectivetauseedingassaysandisoformspecificantibodiesdefineneuroanatomicdistributionofprogressivesupranuclearpalsypathologyarisinginalzheimersdisease
AT goodwillvanessas selectivetauseedingassaysandisoformspecificantibodiesdefineneuroanatomicdistributionofprogressivesupranuclearpalsypathologyarisinginalzheimersdisease
AT standkeheidig selectivetauseedingassaysandisoformspecificantibodiesdefineneuroanatomicdistributionofprogressivesupranuclearpalsypathologyarisinginalzheimersdisease
AT kimyongya selectivetauseedingassaysandisoformspecificantibodiesdefineneuroanatomicdistributionofprogressivesupranuclearpalsypathologyarisinginalzheimersdisease
AT coleynicolas selectivetauseedingassaysandisoformspecificantibodiesdefineneuroanatomicdistributionofprogressivesupranuclearpalsypathologyarisinginalzheimersdisease
AT pizzodonaldp selectivetauseedingassaysandisoformspecificantibodiesdefineneuroanatomicdistributionofprogressivesupranuclearpalsypathologyarisinginalzheimersdisease
AT galaskodouglas selectivetauseedingassaysandisoformspecificantibodiesdefineneuroanatomicdistributionofprogressivesupranuclearpalsypathologyarisinginalzheimersdisease
AT krausallison selectivetauseedingassaysandisoformspecificantibodiesdefineneuroanatomicdistributionofprogressivesupranuclearpalsypathologyarisinginalzheimersdisease
AT hinikerannie selectivetauseedingassaysandisoformspecificantibodiesdefineneuroanatomicdistributionofprogressivesupranuclearpalsypathologyarisinginalzheimersdisease